CD8A and neoplasm: The CD8α+ (mouse) and CD141+ (human) type 1 cDC (cDC1) subtype efficiently presents major histocompatibility complex (MHC) class 1 antigens to CD8+ T cells, initializing potent anti-tumor immune responses in “hot” tumors [119,120].